PRGO FY 2024 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.4B-6.1% YoY

Gross Profit

$1.5B35.3% margin

Operating Income

$113M2.6% margin

Net Income

-$172M-3.9% margin

EPS (Diluted)

$-1.25

Cash Flow

Operating Cash Flow

$363M

Free Cash Flow

$245M

Stock-Based Comp.

$64M

Balance Sheet

Total Assets

$9.6B

Total Liabilities

$5.3B

Stockholders' Equity

$4.3B

Cash & Equivalents

$559M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.4B	$4.7B	-6.1%
Gross Profit	$1.5B	$1.7B	-8.2%
Operating Income	$113M	$152M	-25.7%
Net Income	-$172M	-$13M	-1252.8%